BioSpace - Print News Article

Abbott Laboratories (ABT) Challenges $1.67 Billion Patent Loss to Johnson & Johnson (JNJ) Over Humira 11/3/2010 7:53:57 AM Bloomberg -- Abbott Laboratories urged a U.S. appeals court to throw out a $1.67 billion patent-infringement verdict, the largest in U.S. history, set after a jury found the company used Johnson & Johnson’s technology to develop the arthritis drug Humira.

Abbott Laboratories (ABT) Challenges $1.67 Billion Patent Loss to Johnson & Johnson (JNJ) Over Humira
11/3/2010 7:53:57 AM

Bloomberg -- Abbott Laboratories urged a U.S. appeals court to throw out a $1.67 billion patent-infringement verdict, the largest in U.S. history, set after a jury found the company used Johnson & Johnson’s technology to develop the arthritis drug Humira.